Weekly Newsletter Signup | Vendors, CIO Viewpoint, CXO Insights

Weekly Brief


Weekly Brief

Thursday, September 12,2019

Feature of the Week

Owing to its ability to manipulate and analyze the three-dimensional structures of proteins and molecules, VR is increasingly getting incorporated into drug discovery processes.  Read more
Robust ERP software will not help them in organizing their procurement processes, but will also enhance productivity by streamlining production and reducing delivery time.  Read more
A pharmaceutical industry CRM can decrease heavy manufacturing expenses and the need for delivery of services.  Read more

CIO Viewpoint

By Kristin Darby, CIO, Cancer Treatment Centers of America (CTCA)  
The rapid decrease in the cost of DNA sequencing that has occurred since 2008 has ignited innovation in the precision medicine area.  Read more
By William Phillips,SVP & CIO,University Health System  
One of the largest challenges is to establish Data Governance in Healthcare. The new buzz word in health information technology is big data.  Read more

Featured Vendors

By Dr. Yoshinori Ikeura, President and CEO  
Provides comprehensive capabilities to enhance a client’s ability to identify novel and efficacious targets  Read more
By Dr. Jin-San Yoo, President and CEO  
PharmAbcine’s HuPhage library is a fully human antibody library with 1011 diversity and highest quality. By using HuPhage antibody library and selection, PharmAbcine has been able to isolate Olinvacimab, which is an anti-human VEGFR2 (KDR)...  Read more
By Hideyuki Hirama, President and CEODr. Ryoichi Nagata Chairman  
Gemseki offers an open marketplace, the “Drug Candidate Marketplace” to list drug candidates, therapeutic targets, and drug discovery technologies (“assets”) available for partnering and licensing. With Gemseki’s Drug Candidate...  Read more

CXO Insights

By Jinesh Jain, Director of Clinical Technology, Somnoware Healthcare Systems Inc.  
The rapid adoption of cloud computing in routine clinical practice has led to the incubation of...  Read more
By Marie McCarthy, Director, Product Innovation, ICON plc  
The existing clinical trial design is under increased scrutiny with lengthening trials.  Read more